Oct 17 (Reuters) - Acerus Pharmaceuticals Corporation ASP.TO
* Acerus Pharmaceuticals - signing of agreement granting eu hwa pte ltd exclusive right to market NATESTO in Thailand, Malaysia/Brunei, among others
* Acerus Pharmaceuticals -under agreement, co to receive non-refundable upfront fee, eligible to get milestone upon submission of some data to sea partner
* Acerus Pharmaceuticals Corporation - under terms of agreement co will oversee manufacturing of NATESTO and will receive a supply price for product